Change Country
Welcome to Belgium
Please read the important information below before continuing to our website

The UCITS ETFs listed on this website are funds under both Amundi ETF and Lyxor ETF denomination.

The Lyxor ETFs on this website may be restricted for certain individuals or in certain countries pursuant to the national regulations applicable to those individuals or countries. It is therefore your responsibility to ensure that you are authorised to invest in the Lyxor ETFs on this website. 

If you are an investor in the United Kingdom, please go to  

If you are an investor in the Netherlands, please go to  

If you are an investor in Italy, please go to  

If you are an investor in Spain, please go to  

If you are an investor in Austria, please go to  

If you are an investor in Germany, please go to   

If you are an investor in Singapore, please go to  

If you are an investor in Switzerland, please go to  

If you are an investor in Belgium, please go to  

If you are an investor in Poland, please go to 

If you are an investor in Norway, please go to

If you are an investor in Denmark, please go to

If you are an investor in Luxembourg, please go to

If you are an investor in Sweden, please go to

If you are an investor in Finland, please go to

The Lyxor ETFs on this website are undertakings for collective investment in transferable securities (UCITS) (i) domiciled in France and approved by the Autorité des Marchés Financiers (AMF) or, (ii) domiciled in Luxembourg, approved by the Commission de Surveillance du Secteur Financier (CSSF) and authorised to market their units or shares in the French Republic in accordance with the notification procedure under Article 93 of Directive 2009/65/EC. Investors should note that the prospectuses of certain Lyxor ETFs under Luxembourg law that have been notified in accordance with this procedure are only available on the website in English. A French translation of these prospectuses can be obtained upon request by sending a letter to Lyxor International Asset Management (“Lyxor”) – 91-93, boulevard Pasteur, 75015 Paris -France.

The information on this website is not intended for persons or entities that are resident, located or registered in jurisdictions that are not authorised to distribute Lyxor ETFs. As a result, the information on this website does not constitute an offer or solicitation to buy or sell units or shares in these ETFs by anyone in any jurisdiction:

(a)   in which such an offer or solicitation is unauthorised;

(b)   in which Lyxor is not qualified to make such an offer or solicitation; or 

(c)   in which it is unlawful to make such an offer or solicitation.

In particular, the Lyxor ETFs on this website are not and will not be registered under the United States Securities Act of 1933, as amended. As such, they may not be offered or sold within the United States of America, except in specific cases where transactions are exempt from registration under the Securities Act. The ETFs listed on this website may not be sold to US citizens or transferred to the United States by any other means, unless this transaction is not subject to any specific registration under US law. 

Any person from a jurisdiction to which the above-mentioned restrictions apply should inform themselves of and observe these restrictions.

This website is intended for commercial purposes and is not regulatory in nature. Although the information provided has been drawn up on the basis of sources considered to be reliable, there is no guarantee that it is accurate, complete or relevant. Some of the information on this website is provided on the basis of market data collected at a specific time and may therefore vary over time. Lyxor advises investors to read the risk factors section of the prospectus and the key investor information document carefully. These documents can be found on the website.

The net asset value (“NAV”) of Lyxor ETFs may at any time be subject to considerable price fluctuations, which in some cases may lead to the loss of all of the capital invested. Investors should note that some ETFs may be sensitive to fluctuations in the exchange rate between their reference currency and that of the underlying index, as well as of the components of the underlying index.

Before investing in a Lyxor ETF, you should carry out your own risk analysis of the product from a legal, tax and accounting perspective, rather than basing your decision solely on the information provided. If necessary, you should consult your own advisers or any other qualified professional. 

Subject to compliance with the legal obligations by which they are bound, Lyxor or any entity within the same group shall not be held liable for any financial or other consequences of an investment in the product. 

By clicking on institutional or individual above, I confirm that I have read and understood the information provided herein, and that I am resident or registered in Belgium.

We have a new home

Banner Amundi

Read more
25 Jun 2019


The shareholders are hereby informed that they are invited to attend an extraordinary general meeting to be held Tuesday 25 June 2019 at 11:00 a.m. at Tour Société Générale, 17 cours Valmy - 92800 Puteaux, France, to consider the following business (1) :
- Approval of the planned merger and absorption of the LYXOR RUSSELL 2000 UCITS ETF fund into the LYXOR RUSSELL 2000 UCITS ETC sub-fund (to be created) of the MULTI UNITS France SICAV fund.
- Approval of the proposal to amend Article 28 "Extension or early dissolution" of the articles of association of the MULTI UNITS FRANCE SICAV fund, pursuant to AMF Position–Recommendation No. 2011-25 as amended on 13 March 2019.
- Granting of power to carry out formalities.
(1) If a quorum is not obtained for the first meeting, a second meeting will be held on Friday 12 July 2019 at the same time and with the same agenda.
In order to attend or be represented at the meeting, registered shareholders must have their shares registered directly with the fund or through an intermediary at least two days before the meeting date. Holders of shares in bearer form must, within this same time limit, provide evidence of their identity and of their ownership of their shares by presenting a certificate issued by the authorised registrar that attests to the presence of their shares in their shareholder’s account.
Shareholders may either:
- attend the meeting in person
- give proxy to another shareholder, to their spouse or to a civil partner
- send a proxy voting form to the company without indicating a proxy
- or fill out a postal voting form and send it to the company.
Shareholders may obtain a single proxy / postal voting form from the fund’s registered office.
This form must be requested from the company in writing by registered letter with acknowledgement of receipt no later than six days before the meeting date.
The completed form must be returned such that it is received by the company no later than three days before the meeting date.